How prepared are you to talk about available perioperative immunotherapies for early-stage resectable non-small cell lung cancer (NSCLC) with your patients?

Credit available for this activity expires: 6/30/24 Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/993807?ecd=bdc_podcast_libsyn_mscpedu